Application of a C. elegans dopamine neuron degeneration assay for the validation of potential Parkinson's disease genes.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of Visualized Experiments

• Publication date

  2008-07-18

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3791/835PMID 19066512PMCID PMC3253614
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Parkinson's disease protein α-synuclein disrupts cellular Rab homeostasis

  2008cited by this paper
• Hypothesis-based RNAi screening identifies neuroprotective genes in a Parkinson's disease model

  2008cited by this paper
• The Parkinson's disease protein alpha-synuclein disrupts cellular Rab homeostasis.

  2008cited by this paper
• Integrated Genomics: A Discovery-Based Laboratory Course

  2006cited by this paper
• α-Synuclein Blocks ER-Golgi Traffic and Rab1 Rescues Neuron Loss in Parkinson's Models

  2006cited by this paper
• Torsin-Mediated Protection from Cellular Stress in the Dopaminergic Neurons of Caenorhabditis elegans

  2005cited by this paper
• A simple method for maintaining large, aging populations of Caenorhabditis elegans.

  1980cited by this paper
• The genetics of Caenorhabditis elegans.

  1974cited by this paper

• β-synuclein blocks α-synuclein condensate fusion to disrupt the maturation of phase separation.

  2025cites this paper
• Studying the mechanisms of neurodegeneration: C. elegans advantages and opportunities

  2025cites this paper
• Actinomyces viscosus promotes neuroprotection in C. elegans models of Parkinson's disease.

  2025cites this paper
• Ferrostatin-1 mitigates cellular damage in a ferroptosis-like environment in Caenorhabditis elegans.

  2024cites this paper
• Chiisanoside Mediates the Parkin/ZNF746/PGC-1α Axis by Downregulating MiR-181a to Improve Mitochondrial Biogenesis in 6-OHDA-Caused Neurotoxicity Models In Vitro and In Vivo: Suggestions for Prevention of Parkinson’s Disease

  2023cites this paper
• Mechanistic impacts of bacterial diet on dopaminergic neurodegeneration in a Caenorhabditis elegans α-synuclein model of Parkinson’s disease

  2023cites this paper
• Sink or swim: Does a worm paralysis phenotype hold clues to neurodegenerative disease?

  2023cites this paper
• Deep Learning for Microfluidic-Assisted Caenorhabditis elegans Multi-Parameter Identification Using YOLOv7

  2023cites this paper
• Lipase regulation of cellular fatty acid homeostasis as a Parkinson’s disease therapeutic strategy

  2022cites this paper
• Integrated regulation of dopaminergic and epigenetic effectors of neuroprotection in Parkinson’s disease models

  2022cites this paper
• Systemic RNA Interference Defective (SID) genes modulate dopaminergic neurodegeneration in C. elegans

  2022cites this paper
• Caenorhabditis elegans Model Studies Show MPP+ Is a Simple Member of a Large Group of Related Potent Dopaminergic Toxins.

  2021cites this paper
• Quantifying Levels of Dopaminergic Neuron Morphological Alteration and Degeneration in Caenorhabditis elegans.

  2021cites this paper
• Parkinson's disease and microRNAs - Lessons from model organisms and human studies.

  2021cites this paper
• N-Methyl-4-phenylpyridinium Scaffold-Containing Lipophilic Compounds Are Potent Complex I Inhibitors and Selective Dopaminergic Toxins.

  2019cites this paper
• The potential application of rapeseed pomace extracts in the prevention and treatment of neurodegenerative diseases

  2019cites this paper
• Tyrosol, a simple phenol from EVOO, targets multiple pathogenic mechanisms of neurodegeneration in a C. elegans model of Parkinson's disease.

  2019cites this paper
• Glial loss of the metallo β-lactamase domain containing protein, SWIP-10, induces age- and glutamate-signaling dependent, dopamine neuron degeneration

  2018cites this paper
• A Motor Phenotype of ɑ-Synuclein-Mediated Dopaminergic Neuron Dysfunction in a C. elegans Model

  2018cites this paper
• Virulence test using nematodes to prescreen Nocardia species capable of inducing neurodegeneration and behavioral disorders

  2017cites this paper
• Behavioral Phenotyping and Pathological Indicators of Parkinson's Disease in C. elegans Models

  2017cites this paper
• Glucose‐rich diet aggravates monocrotophos‐induced dopaminergic neuronal dysfunction in Caenorhabditis elegans

  2017cites this paper
• Attenuation of Dopaminergic Neuronal Dysfunction in Caenorhabditis elegans by Hydrophilic Form of Curcumin

  2016cites this paper
• Dietary Plant Lectins Appear to Be Transported from the Gut to Gain Access to and Alter Dopaminergic Neurons of Caenorhabditis elegans, a Potential Etiology of Parkinson’s Disease

  2016cites this paper
• Dietary Plant Lectins May be an �Unknown Etiology� in Parkinson�s Disease and Dietary Bioactive Compounds Affect Lifespan and Fat Storage Aspects of Caenorhabditis Elegans

  2016cites this paper
• Chemical Compensation of Mitochondrial Phospholipid Depletion in Yeast and Animal Models of Parkinson’s Disease

  2016cites this paper
• Mitochondrial pyruvate carrier regulates autophagy, inflammation, and neurodegeneration in experimental models of Parkinson’s disease

  2016cites this paper
• Glutaredoxin deficiency exacerbates neurodegeneration in C. elegans models of Parkinson's disease.

  2015cites this paper
• Reversing deleterious protein aggregation with re-engineered protein disaggregases

  2014cites this paper
• Protective Role of DNJ-27/ERdj5 in Caenorhabditis elegans Models of Human Neurodegenerative Diseases

  2014cites this paper
• Potentiated Hsp104 variants antagonize diverse proteotoxic misfolding events.

  2013cites this paper
• Kinase inhibitors arrest neurodegeneration in cell and C. elegans models of LRRK2 toxicity.

  2013cites this paper
• MODELING LRRK2-ASSOCIATED PARKINSON’S DISEASE IN C. ELEGANS

  2012cites this paper
• C. elegans and Neurodegeneration In Caenorhabditis Elegans: Anatomy, Life Cycles and Biological Functions.

  2012cites this paper
• A molecular readout of long-term olfactory adaptation in C. elegans.

  2012cites this paper
• Caenorhabditis elegans as a model system for identifying effectors of α-synuclein misfolding and dopaminergic cell death associated with Parkinson's disease.

  2011cites this paper
• Methodological Strategies to Evaluate Functional Effectors Related to Parkinson’s Disease Through Application of Caenorhabditis elegans Models

  2011cites this paper
• Sir-2.1 modulates 'calorie-restriction-mediated' prevention of neurodegeneration in Caenorhabditis elegans: implications for Parkinson's disease.

  2011cites this paper
• Watching worms whither: modeling neurodegeneration in C. elegans.

  2011cites this paper
• Modeling dopamine neuron degeneration in Caenorhabditis elegans.

  2011cites this paper
• Invertebrate models for biomedical research, testing, and education.

  2011cites this paper
• Caenorhabditis elegans as a model to assess reproductive and developmental toxicity

  2011cites this paper
• Gene-environment interactions: neurodegeneration in non-mammals and mammals.

  2010cites this paper
• Extracellular Dopamine Potentiates Mn-Induced Oxidative Stress, Lifespan Reduction, and Dopaminergic Neurodegeneration in a BLI-3–Dependent Manner in Caenorhabditis elegans

  2010cites this paper
• LRRK2-mediated neurodegeneration and dysfunction of dopaminergic neurons in a Caenorhabditis elegans model of Parkinson's disease.

  2010cites this paper
• Genetic aspects of behavioral neurotoxicology.

  2009cites this paper